Clorox (CLX) Operating Expenses (2009 - 2026)

Clorox's Operating Expenses history runs 18 years deep, the most recent figure standing at $256.0 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 12.93% year-over-year to $256.0 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 3.12% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 3.71% from the prior year.
• Operating Expenses fell to $256.0 million in Q1 2026 per CLX's latest filing, from $291.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $367.0 million in Q2 2023 and bottomed at $256.0 million in Q1 2026.
• The 5-year median for Operating Expenses is $305.0 million (2023), against an average of $309.0 million.
• Across the five-year window, Operating Expenses jumped 32.01% in 2023 and declined 17.98% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $315.0 million in 2022, then grew by 12.38% to $354.0 million in 2023, then dropped by 12.15% to $311.0 million in 2024, then fell by 6.43% to $291.0 million in 2025, then fell by 12.03% to $256.0 million in 2026.
• Per Business Quant, the three latest CLX Operating Expenses figures stand at $256.0 million (Q1 2026), $291.0 million (Q4 2025), and $305.0 million (Q3 2025).